Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""PREVENTION"" wg kryterium: Temat


Tytuł :
Why primary prevention often is no prevention at all.
Autorzy :
Cuijpers P; Department of Clinical, Neuro and Developmental Psychology, WHO Collaborating Centre for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Van der Boechorststraat 7-9, 1081 BT Amsterdam, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2022 May; Vol. 58, pp. 1-3. Date of Electronic Publication: 2022 Jan 22.
Typ publikacji :
Journal Article
MeSH Terms :
Primary Prevention*
Secondary Prevention
Czasopismo naukowe
Tytuł :
Primary vs. secondary prevention and coronary artery calcium: Shades of grey.
Autorzy :
Ahmed AI; Houston Methodist Debakey Heart & Vascular Center, Houston, TX, USA.
Raggi P; Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada.
Al-Mallah MH; Houston Methodist Debakey Heart & Vascular Center, Houston, TX, USA. Electronic address: .
Pokaż więcej
Źródło :
Atherosclerosis [Atherosclerosis] 2022 Apr; Vol. 347, pp. 68-69. Date of Electronic Publication: 2022 Mar 09.
Typ publikacji :
Editorial
MeSH Terms :
Coronary Artery Disease*/diagnostic imaging
Coronary Artery Disease*/prevention & control
Vascular Calcification*/diagnostic imaging
Vascular Calcification*/prevention & control
Calcium ; Coronary Vessels/diagnostic imaging ; Humans ; Primary Prevention ; Risk Factors ; Secondary Prevention
Opinia redakcyjna
Tytuł :
Guideline-Concordant Statin Therapy Use in Secondary Prevention: Should the Medical Community Wait for Divine Intervention?
Autorzy :
Virani SS; Health Policy, Quality & Informatics Program, Michael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations, Houston, Texas, USA; Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA; Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. Electronic address: .
Ballantyne CM; Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.
Petersen LA; Health Policy, Quality & Informatics Program, Michael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations, Houston, Texas, USA; Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2022 May 10; Vol. 79 (18), pp. 1814-1817.
Typ publikacji :
Editorial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Comment
MeSH Terms :
Cardiovascular Diseases*/prevention & control
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Humans ; Primary Prevention ; Secondary Prevention
Raport
Tytuł :
Our Efforts for Ideal Stroke Prevention and Treatment in Japan.
Autorzy :
Yamaguchi T; National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Pokaż więcej
Źródło :
Stroke [Stroke] 2022 Mar; Vol. 53 (3), pp. 1030-1036. Date of Electronic Publication: 2022 Jan 11.
Typ publikacji :
Journal Article
MeSH Terms :
Primary Prevention*
Secondary Prevention*
Stroke/*prevention & control
Cilostazol/therapeutic use ; Humans ; Japan ; Platelet Aggregation Inhibitors/therapeutic use ; Stroke/therapy
Czasopismo naukowe
Tytuł :
Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials.
Autorzy :
Xu H; Department of Cardiology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
Mao L; Department of Thyroid and Breast Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, Jiangsu, China.
Liu H; Department of Cardiology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
Lin Z; Department of Cardiology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
Zhang Y; Department of Medical Laboratory, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
Yang J; Department of Cardiology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China. Electronic address: .
Pokaż więcej
Źródło :
Heart, lung & circulation [Heart Lung Circ] 2022 May; Vol. 31 (5), pp. 685-695. Date of Electronic Publication: 2022 Jan 13.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Coronary Artery Disease*/drug therapy
Coronary Artery Disease*/prevention & control
Stroke*/prevention & control
Anti-Inflammatory Agents/therapeutic use ; Colchicine/therapeutic use ; Humans ; Randomized Controlled Trials as Topic ; Secondary Prevention
Czasopismo naukowe
Tytuł :
Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020.
Autorzy :
Gladstone DJ; Division of Neurology, Department of Medicine, and Regional Stroke Centre, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre and Sunnybrook Research Institute, Toronto, Canada.
Lindsay MP; Heart and Stroke Foundation of Canada, Toronto, Canada.
Douketis J; Department of Medicine, McMaster University, Hamilton, Canada.
Smith EE; University of Calgary, Cumming School of Medicine, Department of Clinical Neurosciences, Calgary, Canada.
Dowlatshahi D; University of Ottawa, Department of Neurology, Ottawa, Canada.
Wein T; Stroke Prevention Clinic, McGill University Health Centre, Montreal, Canada.
Bourgoin A; Stroke Prevention Clinic, Champlain Regional Stroke Network, Ottawa, Canada.
Cox J; Departments of Medicine and of Community Health and Epidemiology, Dalhousie University, Halifax, Canada.
Falconer JB; Division of Neurology, Faculty of Medicine, University of British Columbia, Kelowna, Canada.
Graham BR; Faculty of Medicine, Department of Neurology, University of Saskatchewan, Saskatoon, Canada.
Labrie M; Faculty of Medicine (Neurology), Laval University, Quebec City, Canada.
McDonald L; Heart Health Clinic, St. Martha's Regional Hospital, Antigonish, Canada.
Mandzia J; Department of Clinical Neurological Sciences, Western University, London, Canada.
Ngui D; Dept of Family Medicine, University of British Columbia, Vancouver, Canada.
Pageau P; The Ottawa Hospital, Department of Emergency Medicine, Ottawa, Canada.
Rodgerson A; Provincial Rehabilitation Unit, Queen Elizabeth Hospital, Charlottetown, Canada.
Semchuk W; College of Pharmacy, University of Saskatchewan, Regina, Canada.
Tebbutt T; District Stroke Centre, Waterloo Wellington, Kitchener, Canada.
Tuchak C; Division of Physical Medicine and Rehabilitation, University of Alberta, Edmonton, Canada.
van Gaal S; Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Villaluna K; Vancouver Stroke Program, Vancouver, Canada.
Foley N; WorkHORSE Consulting Inc., London, Canada.
Coutts S; University of Calgary, Cumming School of Medicine, Department of Clinical Neurosciences, Calgary, Canada.
Mountain A; Queen Elizabeth II Health Sciences Centre, Nova Scotia Rehabilitation Centre Site, Halifax, Canada.
Gubitz G; Queen Elizabeth II Health Sciences Centre, Stroke Program, Halifax, Canada.
Udell JA; Division of Cardiology, Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Canada.
McGuff R; Heart and Stroke Foundation of Canada, Toronto, Canada.
Poppe AY; Department of Neurosciences, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Canada.
Pokaż więcej
Corporate Authors :
Canadian Stroke Consortium
Źródło :
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques [Can J Neurol Sci] 2022 May; Vol. 49 (3), pp. 315-337. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Atrial Fibrillation*
Ischemic Attack, Transient*/complications
Ischemic Attack, Transient*/prevention & control
Ischemic Stroke*
Stroke*/etiology
Stroke*/prevention & control
Anticoagulants/therapeutic use ; Canada/epidemiology ; Female ; Humans ; Male ; Secondary Prevention
Czasopismo naukowe
Tytuł :
Reactions to messages about smoking, vaping and COVID-19: two national experiments.
Autorzy :
Grummon AH; Center for Population and Development Studies, Harvard TH Chan School of Public Health, Cambridge, Massachusetts, USA .; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Hall MG; Department of Health Behavior, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Mitchell CG; Department of Health Behavior, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.
Pulido M; Department of Health Behavior, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.
Mendel Sheldon J; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Noar SM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Hussman School of Journalism and Media, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Ribisl KM; Department of Health Behavior, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Brewer NT; Department of Health Behavior, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Pokaż więcej
Źródło :
Tobacco control [Tob Control] 2022 May; Vol. 31 (3), pp. 402-410. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/prevention & control
Electronic Nicotine Delivery Systems*
Health Communication*
Smoking*/adverse effects
Vaping*/adverse effects
Vaping*/prevention & control
Adult ; Humans ; Pandemics ; Smoking Prevention
Czasopismo naukowe
Tytuł :
Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis.
Autorzy :
Cabiddu MF; School of Hospital Pharmacy, University of Florence Faculty of Pharmacy, Firenze, Toscana, Italy.
Russi A; School of Hospital Pharmacy, University of Padua Department of Pharmaceutical and Pharmacological Sciences, Padova, Italy .
Appolloni L; Farmacia Clinica, Policlinico S.Orsola-Malpighi, Bologna, Italy.
Mengato D; Department of Hospital Pharmacy, Bolzano Hospital, Bolzano, Trentino-Alto Adige, Italy.
Chiumente M; Scientific Direction, Italian Society for Clinical Pharmacy, Milan, Italy.
Pokaż więcej
Źródło :
European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2022 May; Vol. 29 (3), pp. 134-138. Date of Electronic Publication: 2020 Jun 16.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Cardiovascular Diseases*/diagnosis
Cardiovascular Diseases*/drug therapy
Cardiovascular Diseases*/prevention & control
Fatty Acids, Omega-3*/therapeutic use
Humans ; Primary Prevention/methods ; Randomized Controlled Trials as Topic ; Secondary Prevention/methods
Czasopismo naukowe
Tytuł :
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease.
Autorzy :
Gallagher H; SW Thames Renal Unit, Epsom and St Helier University Hospitals NHS Trust, Epsom, UK. .
Dumbleton J; Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
Maishman T; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
Whitehead A; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
Moore MV; Department of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Fuat A; School of Medicine, Pharmacy and Health, Durham University, Durham, UK.; Carmel Medical Practice, Nunnery Lane, Darlington, UK.
Fitzmaurice D; University of Warwick, Coventry, CV4 7AL, UK.
Henderson RA; Trent Cardiac Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Lord J; Health Technology Assessment Centre, Faculty of Medicine, University of Southampton, Southampton, UK.
Griffith KE; York, UK.
Stevens P; Kent Kidney Care Centre, East Kent Hospitals University Foundation Trust, Canterbury, UK.
Taal MW; School of Medicine, University of Nottingham, Nottingham, UK.; University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
Stevenson D; Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
Fraser SD; Department of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Lown M; Department of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Hawkey CJ; Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK.
Roderick PJ; Department of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Pokaż więcej
Źródło :
Trials [Trials] 2022 Apr 21; Vol. 23 (1), pp. 331. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji :
Clinical Trial Protocol; Journal Article
MeSH Terms :
Cardiovascular Diseases*/chemically induced
Cardiovascular Diseases*/diagnosis
Cardiovascular Diseases*/prevention & control
Myocardial Infarction*/diagnosis
Myocardial Infarction*/prevention & control
Renal Insufficiency, Chronic*/complications
Renal Insufficiency, Chronic*/diagnosis
Stroke*/drug therapy
Adolescent ; Adult ; Aspirin/adverse effects ; Female ; Hemorrhage/chemically induced ; Hemorrhage/drug therapy ; Humans ; Male ; Multicenter Studies as Topic ; Platelet Aggregation Inhibitors/adverse effects ; Primary Prevention/methods ; Prospective Studies ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
Strengthening Primary Healthcare in Kosovo Requires Tailoring Primary, Secondary and Tertiary Prevention Interventions and Consideration of Mental Health.
Autorzy :
Obas KA; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Bytyci-Katanolli A; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Kwiatkowski M; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Ramadani Q; Accessible Quality Healthcare Project, Prishtina, Kosovo.
Fota N; Accessible Quality Healthcare Project, Prishtina, Kosovo.
Jerliu N; National Institute of Public Health, Prishtina, Kosovo.; Medical Faculty, University of Prishtina, Prishtina, Kosovo.
Statovci S; University Clinical Centre of Kosovo, Prishtina, Kosovo.
Gerold J; University of Basel, Basel, Switzerland.; Swiss Center for International Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Zahorka M; University of Basel, Basel, Switzerland.; Swiss Center for International Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Probst-Hensch N; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Pokaż więcej
Źródło :
Frontiers in public health [Front Public Health] 2022 Apr 05; Vol. 10, pp. 794309. Date of Electronic Publication: 2022 Apr 05 (Print Publication: 2022).
Typ publikacji :
Journal Article
MeSH Terms :
Diabetes Mellitus*/epidemiology
Diabetes Mellitus*/prevention & control
Hypertension*
Noncommunicable Diseases*
Pulmonary Disease, Chronic Obstructive*/complications
Pulmonary Disease, Chronic Obstructive*/epidemiology
Pulmonary Disease, Chronic Obstructive*/prevention & control
Cross-Sectional Studies ; Depression/diagnosis ; Depression/epidemiology ; Humans ; Kosovo/epidemiology ; Mental Health ; Primary Health Care ; Tertiary Prevention
Czasopismo naukowe
Tytuł :
Comparison of American and European Guidelines for Primary Prevention of Cardiovascular Disease: JACC Guideline Comparison.
Autorzy :
Fegers-Wustrow I; Department of Prevention and Sports Medicine, University Hospital Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Gianos E; Zucker School of Medicine at Hofstra, New York, New York, USA; Lenox Hill Hospital, New York, New York, USA; Northwell Health, New York, New York, USA.
Halle M; Department of Prevention and Sports Medicine, University Hospital Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Yang E; Division of Cardiology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA. Electronic address: .
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2022 Apr 05; Vol. 79 (13), pp. 1304-1313.
Typ publikacji :
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms :
Cardiology*
Cardiovascular Diseases*/prevention & control
American Heart Association ; Humans ; Primary Prevention ; Risk Factors ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Long-Term Secondary Prevention: Management of Blood Pressure After a Transient Ischemic Attack or Stroke.
Autorzy :
McGurgan IJ; Wolfson Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom (I.J.M., P.M.R.).
Kelly PJ; Neurovascular Clinical Science Unit, Stroke Service and Department of Neurology, Mater University Hospital, Dublin, Ireland (P.J.K.).
Turan TN; Department of Neurology, Medical University of South Carolina, Charleston (T.N.T.).
Rothwell PM; Wolfson Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom (I.J.M., P.M.R.).
Pokaż więcej
Źródło :
Stroke [Stroke] 2022 Apr; Vol. 53 (4), pp. 1085-1103. Date of Electronic Publication: 2022 Mar 16.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Ischemic Attack, Transient*/drug therapy
Ischemic Attack, Transient*/prevention & control
Stroke*/drug therapy
Stroke*/prevention & control
Antihypertensive Agents/pharmacology ; Antihypertensive Agents/therapeutic use ; Blood Pressure/physiology ; Humans ; Secondary Prevention
Czasopismo naukowe
Tytuł :
Role of diabetologists in the management of nonalcoholic fatty liver disease: Primary prevention and screening/management of fibrosis and cirrhosis.
Autorzy :
Kuchay MS; Division of Endocrinology and Diabetes, Medanta The Medicity Hospital, Gurugram, 122001, Haryana, India. Electronic address: .
Misra A; Fortis CDOC Hospital for Diabetes and Allied Sciences, New Delhi, India; National Diabetes Obesity and Cholesterol Foundation (NDOC) and Diabetes Foundation, India. Electronic address: .
Pokaż więcej
Źródło :
Diabetes & metabolic syndrome [Diabetes Metab Syndr] 2022 Mar; Vol. 16 (3), pp. 102446. Date of Electronic Publication: 2022 Feb 28.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Diabetes Mellitus, Type 2*/complications
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/etiology
Non-alcoholic Fatty Liver Disease*/prevention & control
Physicians*
Humans ; Liver ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/etiology ; Liver Cirrhosis/prevention & control ; Primary Prevention
Czasopismo naukowe
Tytuł :
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
Autorzy :
Cleland JGF; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Pokaż więcej
Źródło :
Thrombosis and haemostasis [Thromb Haemost] 2022 Mar; Vol. 122 (3), pp. 311-314. Date of Electronic Publication: 2022 Jan 20.
Typ publikacji :
Editorial
MeSH Terms :
Aspirin*/therapeutic use
Cardiovascular Diseases*/prevention & control
Humans ; Platelet Aggregation Inhibitors/therapeutic use ; Primary Prevention ; Secondary Prevention
Opinia redakcyjna
Tytuł :
Feasibility and preliminary effectiveness of internet-mediated 'relapse prevention therapy' for patients with alcohol use disorder: A pilot study.
Autorzy :
Sharma A; National Institute of Nursing Education, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Das K; National Institute of Nursing Education, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sharma S; National Institute of Nursing Education, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Ghosh A; Department of Psychiatry and Drug De-addiction and Treatment Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pokaż więcej
Źródło :
Drug and alcohol review [Drug Alcohol Rev] 2022 Mar; Vol. 41 (3), pp. 641-645. Date of Electronic Publication: 2021 Oct 27.
Typ publikacji :
Journal Article
MeSH Terms :
Alcoholism*/prevention & control
Adult ; Alcohol Drinking/prevention & control ; Feasibility Studies ; Humans ; Internet ; Male ; Pilot Projects ; Secondary Prevention/methods
Czasopismo naukowe
Tytuł :
Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical Trial.
Autorzy :
Chow CK; Westmead Applied Research Institute (C.K.C., H.K., A.T., A.V.H., A.R.), University of Sydney, Australia.; Department of Cardiology, Westmead Hospital, Sydney, Australia (C.K.C., H.K., A.T.).
Klimis H; Westmead Applied Research Institute (C.K.C., H.K., A.T., A.V.H., A.R.), University of Sydney, Australia.; Department of Cardiology, Westmead Hospital, Sydney, Australia (C.K.C., H.K., A.T.).
Thiagalingam A; Westmead Applied Research Institute (C.K.C., H.K., A.T., A.V.H., A.R.), University of Sydney, Australia.; Department of Cardiology, Westmead Hospital, Sydney, Australia (C.K.C., H.K., A.T.).
Redfern J; Faculty of Medicine and Health (J.R., R.B., M.A.F., M.M.), University of Sydney, Australia.
Hillis GS; University of Western Australia, Perth (G.S.H., P.T.).; Department of Cardiology, Royal Perth Hospital, Australia (G.S.H.).
Brieger D; ANZAC Research Institute (D.B.), University of Sydney, Australia.
Atherton J; Department of Cardiology, Royal Brisbane and Women's Hospital, Brisbane, Australia (J.A.).; The University of Queensland, Brisbane, Australia (J.A., C.H.C.).
Bhindi R; Faculty of Medicine and Health (J.R., R.B., M.A.F., M.M.), University of Sydney, Australia.; Department of Cardiology, Royal North Shore Hospital, Sydney, Australia (R.B.).
Chew DP; College of Medicine and Public Health, Flinders University, Adelaide, South Australia (D.P.C., N.K.).
Collins N; Hunter Medical Research Institute, Newcastle, Australia (N.C.).
Andrew Fitzpatrick M; Faculty of Medicine and Health (J.R., R.B., M.A.F., M.M.), University of Sydney, Australia.
Juergens C; Faculty of Medicine, The University of New South Wales, Sydney, Australia (C.J.).; Department of Cardiology, Liverpool Hospital, Sydney, Australia (C.J.).
Kangaharan N; College of Medicine and Public Health, Flinders University, Adelaide, South Australia (D.P.C., N.K.).; Department of Cardiology, Royal Darwin Hospital, Darwin, Australia (N.K.).; Menzies School of Health Research, Darwin, Australia (N.K.).
Maiorana A; Allied Health Department, Fiona Stanley Hospital, Perth, Australia (A.M.).; School of Allied Health, Curtin University, Perth, Australia (A.M.).
McGrady M; Faculty of Medicine and Health (J.R., R.B., M.A.F., M.M.), University of Sydney, Australia.; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia (M.M.).
Poulter R; Department of Cardiology, Sunshine Coast University Hospital, Brisbane, Australia (R.P.).
Shetty P; Department of Cardiology, Wollongong and Shellharbour Hospitals, Wollongong, Australia (P.S.).
Waites J; Coffs Cardiology, Coffs Harbour, Australia (J.W.).
Hamilton Craig C; The University of Queensland, Brisbane, Australia (J.A., C.H.C.).; Department of Cardiology, Prince Charles Hospital, Brisbane, Australia (C.H.C.).
Thompson P; University of Western Australia, Perth (G.S.H., P.T.).; Department of Cardiology, Sir Charles Gairdner Hospital, Perth, Australia (P.T.).; Harry Perkins Institute of Medical Research, Perth, Australia (P.T.).
Stepien S; The George Institute for Global Health, Sydney, Australia (C.K.C., H.K., A.R., G.S.H., S.S., A.R.).
Von Huben A; Westmead Applied Research Institute (C.K.C., H.K., A.T., A.V.H., A.R.), University of Sydney, Australia.
Rodgers A; Westmead Applied Research Institute (C.K.C., H.K., A.T., A.V.H., A.R.), University of Sydney, Australia.
Pokaż więcej
Corporate Authors :
TEXTMEDS Investigators*
Źródło :
Circulation [Circulation] 2022 May 10; Vol. 145 (19), pp. 1443-1455. Date of Electronic Publication: 2022 May 09.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Acute Coronary Syndrome*/drug therapy
Acute Coronary Syndrome*/prevention & control
Text Messaging*
Australia ; Female ; Humans ; Male ; Medication Adherence ; Middle Aged ; Secondary Prevention ; Single-Blind Method
Czasopismo naukowe
Tytuł :
Comparative efficacy of BG-Sentinel 2 and CDC-like mosquito traps for monitoring potential malaria vectors in Europe.
Autorzy :
Bertola M; Istituto Zooprofilattico Sperimentale delle Venezie, 35020, Legnaro, Padua, Italy.
Fornasiero D; Istituto Zooprofilattico Sperimentale delle Venezie, 35020, Legnaro, Padua, Italy.
Sgubin S; Istituto Zooprofilattico Sperimentale delle Venezie, 35020, Legnaro, Padua, Italy.
Mazzon L; Department of Agronomy, Food, Natural Resources, Animals and Environment (DAFNAE), University of Padova, 35020, Legnaro, Padua, Italy.
Pombi M; Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Montarsi F; Istituto Zooprofilattico Sperimentale delle Venezie, 35020, Legnaro, Padua, Italy. .; Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy. .
Pokaż więcej
Źródło :
Parasites & vectors [Parasit Vectors] 2022 May 07; Vol. 15 (1), pp. 160. Date of Electronic Publication: 2022 May 07.
Typ publikacji :
Journal Article
MeSH Terms :
Aedes*
Anopheles*
Culex*
Malaria*/prevention & control
Animals ; Carbon Dioxide ; Centers for Disease Control and Prevention, U.S. ; Europe ; Humans ; Mosquito Control/methods ; Mosquito Vectors ; United States
Czasopismo naukowe
Tytuł :
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
Autorzy :
Wells GA; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
Hsieh SC; Cardiovascular Research Methods Center, University of Ottawa Heart Institute, Ottawa, Canada.
Zheng C; University of Ottawa Heart Institute, Ottawa, Canada.; Statistics Canada, Ottawa, Canada.
Peterson J; Clinical Epidemiology Unit, Ottawa Civic Hospital / Loeb Research Institute, Ottawa, Canada.
Tugwell P; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.; Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.; WHO Collaborating Centre for Knowledge Translation and Health Technology Assessment in Health Equity, Bruyère Research Institute, Ottawa, Canada.
Liu W; Cardiovascular Research Methods Center, University of Ottawa Heart Institute, Ottawa, Canada.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2022 May 03; Vol. 5. Cochrane AN: CD004523. Date of Electronic Publication: 2022 May 03.
Typ publikacji :
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms :
Hip Fractures*
Osteoporosis*
Osteoporosis, Postmenopausal*/complications
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis, Postmenopausal*/prevention & control
Osteoporotic Fractures*/prevention & control
Radius Fractures*
Spinal Fractures*/prevention & control
Wrist Injuries*
Aged ; Female ; Humans ; Postmenopause ; Risedronic Acid/adverse effects ; Secondary Prevention
Czasopismo naukowe
Tytuł :
Non-monetary incentives for tobacco prevention among youth in Indonesia.
Autorzy :
Triyana M; Wake Forest University, United States.
White JS; Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, United States. Electronic address: .
Pokaż więcej
Źródło :
Journal of health economics [J Health Econ] 2022 May; Vol. 83, pp. 102620. Date of Electronic Publication: 2022 Apr 09.
Typ publikacji :
Journal Article
MeSH Terms :
Motivation*
Smoking Prevention*
Adolescent ; Child ; Humans ; Indonesia ; Tobacco ; Tobacco Use/prevention & control
Czasopismo naukowe
Tytuł :
The Challenges in the Primary Prevention of Osteoarthritis.
Autorzy :
Runhaar J; Department of General Practice, Erasmus MC University Medical Center Rotterdam, PO-Box 2040, Rotterdam 3000 CA, the Netherlands. Electronic address: .
Bierma-Zeinstra SMA; Department of General Practice and Orthopedics & Sports Medicine, Erasmus MC University Medical Center Rotterdam, PO-box 2040, Rotterdam 3000 CA, the Netherlands.
Pokaż więcej
Źródło :
Clinics in geriatric medicine [Clin Geriatr Med] 2022 May; Vol. 38 (2), pp. 259-271.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Osteoarthritis*/diagnosis
Osteoarthritis*/prevention & control
Humans ; Primary Prevention
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies